Ibrutinib and panitumumab used in combination safely in a patient with metachronous colorectal cancer and chronic lymphocytic leukemia.
- Resource Type
- Article
- Source
- Anti-Cancer Drugs; Sup2022, Vol. 33 Issue 8, p765-767, 3p
- Subject
- Language
- ISSN
- 09594973